Schedule 4 Monitoring for indicative dose and analytical performance characteristics 1Monitoring for compliance with the indicative dose 2Screening for certain radionuclides, or screening for an individual radionuclide 3Screening strategies for gross alpha activity and gross beta activity 4Calculation of the indicative dose ← Paragraph Schedule 4 Paragraph 1 →